Ireland - Financial Media Contact
Sodali
2025 Interim Report
RNS Announcements
Investee Companies
Tue, 04 Nov 2025
Block listing Interim Review
Wed, 27 Aug 2025
Wed, 28 May 2025
Director/PDMR Shareholding
Tue, 06 May 2025
Tue, 08 Apr 2025
Holding(s) in Company
News Archive>
26 Nov 2025
Mycovia Pharmaceuticals, Inc. Announces Publication of 2-Year VIVJOA® Efficacy Results from an Extension of the VIOLET Phase 3 Studies in Women with Recurrent Vulvovaginal Candidiasis (RVVC) in the Journal of Women’s Health
11 Dec 2024
Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting
07 Nov 2024
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024
24 Oct 2024
Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema
17 Oct 2024
Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche
